X
Xilio Therapeutics Inc
NASDAQ:XLO
Xilio Therapeutics Inc
NASDAQ:XLO
Price:
7.86
USD
Market Closed
Market Cap:
$530.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
X
|
Xilio Therapeutics Inc
NASDAQ:XLO
|
US |
|
A
|
Allianz Saudi Fransi Cooperative Insurance Company SJSC
SAU:8040
|
SA |
|
Weir Group PLC
LSE:WEIR
|
UK |
|
Bright Horizons Family Solutions Inc
NYSE:BFAM
|
US |
|
GreenMobility A/S
CSE:GREENM
|
DK |
|
KYB Corp
TSE:7242
|
JP |
|
Uflex Ltd
NSE:UFLEX
|
IN |
|
D
|
Dark Star Minerals Inc
CNSX:BATT
|
CA |
|
M
|
Madras Fertilizers Ltd
NSE:MADRASFERT
|
IN |
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
IL |
|
Y
|
Yulon Nissan Motor Co Ltd
TWSE:2227
|
TW |
|
Hindustan Tin Works Ltd
BSE:530315
|
IN |
|
T
|
Toyo Machinery & Metal Co Ltd
TSE:6210
|
JP |
|
Tirupati Graphite PLC
LSE:TGR
|
UK |
|
SEMrush Holdings Inc
NYSE:SEMR
|
US |
|
TAG Oil Ltd
XTSX:TAO
|
CA |
|
Future PLC
LSE:FUTR
|
UK |
|
H
|
Henderson Investment Ltd
HKEX:97
|
HK |
|
Novocure Ltd
NASDAQ:NVCR
|
JE |
|
Halfords Group PLC
LSE:HFD
|
UK |
|
Victory Securities (Holdings) Company Ltd
HKEX:8540
|
HK |
|
Taiwan Pelican Express Co Ltd
TWSE:2642
|
TW |
|
Wardwizard Innovations & Mobility Ltd
BSE:538970
|
IN |
Income Statement
Earnings Waterfall
Xilio Therapeutics Inc
Xilio Therapeutics Inc
Income Statement
Xilio Therapeutics Inc
Xilio Therapeutics Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
1
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
5
+96%
|
6
+37%
|
9
+46%
|
15
+62%
|
32
+112%
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(55)
|
(63)
|
(75)
|
(76)
|
(75)
|
(80)
|
(81)
|
(86)
|
(89)
|
(91)
|
(87)
|
(84)
|
(79)
|
(72)
|
(69)
|
(69)
|
(66)
|
(66)
|
(72)
|
(76)
|
|
| Selling, General & Administrative |
(11)
|
(13)
|
(16)
|
(19)
|
(24)
|
(25)
|
(28)
|
(30)
|
(30)
|
(31)
|
(30)
|
(29)
|
(27)
|
(26)
|
(25)
|
(25)
|
(25)
|
(27)
|
(28)
|
(29)
|
|
| Research & Development |
(44)
|
(50)
|
(59)
|
(58)
|
(51)
|
(54)
|
(53)
|
(56)
|
(59)
|
(60)
|
(57)
|
(55)
|
(52)
|
(46)
|
(44)
|
(44)
|
(41)
|
(39)
|
(43)
|
(47)
|
|
| Operating Income |
(55)
N/A
|
(63)
-16%
|
(75)
-18%
|
(76)
-2%
|
(75)
+1%
|
(80)
-6%
|
(81)
-2%
|
(86)
-5%
|
(89)
-4%
|
(91)
-3%
|
(87)
+5%
|
(84)
+3%
|
(79)
+6%
|
(72)
+9%
|
(67)
+8%
|
(64)
+4%
|
(60)
+7%
|
(57)
+5%
|
(57)
+1%
|
(44)
+23%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
(1)
|
0
|
0
|
0
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
(0)
|
0
|
(0)
|
(15)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
1
|
2
|
3
|
4
|
4
|
3
|
3
|
3
|
2
|
2
|
3
|
0
|
1
|
|
| Pre-Tax Income |
(55)
N/A
|
(64)
-15%
|
(75)
-18%
|
(77)
-2%
|
(76)
+1%
|
(80)
-6%
|
(82)
-2%
|
(85)
-4%
|
(88)
-3%
|
(90)
-1%
|
(84)
+6%
|
(81)
+4%
|
(76)
+6%
|
(71)
+7%
|
(66)
+8%
|
(63)
+4%
|
(58)
+7%
|
(54)
+7%
|
(56)
-4%
|
(58)
-4%
|
|
| Net Income | |||||||||||||||||||||
| Income from Continuing Operations |
(55)
|
(64)
|
(75)
|
(77)
|
(76)
|
(80)
|
(82)
|
(85)
|
(88)
|
(90)
|
(84)
|
(81)
|
(76)
|
(71)
|
(66)
|
(63)
|
(58)
|
(54)
|
(56)
|
(58)
|
|
| Net Income (Common) |
(55)
N/A
|
(64)
-15%
|
(75)
-18%
|
(77)
-2%
|
(76)
+1%
|
(80)
-6%
|
(82)
-2%
|
(85)
-4%
|
(88)
-3%
|
(90)
-1%
|
(84)
+6%
|
(81)
+4%
|
(76)
+6%
|
(71)
+7%
|
(66)
+8%
|
(63)
+4%
|
(58)
+7%
|
(54)
+7%
|
(56)
-4%
|
(58)
-4%
|
|
| EPS (Diluted) |
-2.07
N/A
|
-2.4
-16%
|
-2.84
-18%
|
-2.89
-2%
|
-2.84
+2%
|
-2.94
-4%
|
-2.99
-2%
|
-3.11
-4%
|
-3.22
-4%
|
-3.27
-2%
|
-3.07
+6%
|
-2.96
+4%
|
-2.78
+6%
|
-2.54
+9%
|
-1.13
+56%
|
-0.98
+13%
|
-1.09
-11%
|
-0.72
+34%
|
-0.58
+19%
|
-0.4
+31%
|
|
Switch to:
Switch to:
See Also
Discover More
